Gleissman H - Search Results

1

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Gleissman H, Yang R, Martinod K, Lindskog M, Serhan CN, Johnsen JI, Kogner P. Gleissman H, et al. FASEB J. 2010 Mar;24(3):906-15. doi: 10.1096/fj.09-137919. Epub 2009 Nov 4. FASEB J. 2010. PMID: 19890019 Free PMC article.

2

Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress.

Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen JI. Lindskog M, et al. Among authors: gleissman h. Int J Cancer. 2006 May 15;118(10):2584-93. doi: 10.1002/ijc.21555. Int J Cancer. 2006. PMID: 16353135 Free article.

3

Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.

Gleissman H, Segerström L, Hamberg M, Ponthan F, Lindskog M, Johnsen JI, Kogner P. Gleissman H, et al. Int J Cancer. 2011 Apr 1;128(7):1703-11. doi: 10.1002/ijc.25473. Epub 2010 May 24. Int J Cancer. 2011. PMID: 20499314 Free article.

4

Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo.

Ponthan F, Wickström M, Gleissman H, Fuskevåg OM, Segerström L, Sveinbjörnsson B, Redfern CP, Eksborg S, Kogner P, Johnsen JI. Ponthan F, et al. Among authors: gleissman h. Clin Cancer Res. 2007 Feb 1;13(3):1036-44. doi: 10.1158/1078-0432.CCR-06-1908. Clin Cancer Res. 2007. PMID: 17289900

5

Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo.

Palmberg E, Johnsen JI, Paulsson J, Gleissman H, Wickström M, Edgren M, Ostman A, Kogner P, Lindskog M. Palmberg E, et al. Among authors: gleissman h. Int J Cancer. 2009 Mar 1;124(5):1227-34. doi: 10.1002/ijc.24069. Int J Cancer. 2009. PMID: 19058199 Free article.

6

Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?

Gleissman H, Johnsen JI, Kogner P. Gleissman H, et al. Exp Cell Res. 2010 May 1;316(8):1365-73. doi: 10.1016/j.yexcr.2010.02.039. Epub 2010 Mar 6. Exp Cell Res. 2010. PMID: 20211172 Review.

7

Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E₂ and suppress tumor growth in medulloblastoma.

Ljungblad L, Bergqvist F, Tümmler C, Madawala S, Olsen TK, Andonova T, Jakobsson PJ, Johnsen JI, Pickova J, Strandvik B, Kogner P, Gleissman H, Wickström M. Ljungblad L, et al. Among authors: gleissman h. Life Sci. 2022 Apr 15;295:120394. doi: 10.1016/j.lfs.2022.120394. Epub 2022 Feb 11. Life Sci. 2022. PMID: 35157910 Free article.

8

Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children.

Ljungblad L, Gleissman H, Hedberg G, Wickström M, Eissler N, Pickova J, Johnsen JI, Tedroff K, Strandvik B, Kogner P. Ljungblad L, et al. Among authors: gleissman h. Prostaglandins Leukot Essent Fatty Acids. 2021 Jun;169:102285. doi: 10.1016/j.plefa.2021.102285. Epub 2021 Apr 24. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 33964665 Free article. Clinical Trial.

9

Prone positioning in mechanically ventilated patients with severe acute respiratory distress syndrome and coronavirus disease 2019.

Gleissman H, Forsgren A, Andersson E, Lindqvist E, Lipka Falck A, Cronhjort M, Dahlberg M, Günther M. Gleissman H, et al. Acta Anaesthesiol Scand. 2021 Mar;65(3):360-363. doi: 10.1111/aas.13741. Epub 2020 Nov 22. Acta Anaesthesiol Scand. 2021. PMID: 33165936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page